Acceptance of preventive treatment in migraine patients: Results of a survey

European Journal of General Practice

Volumn 18, Issue 3, 2012, Pages 143-148

  Smelt, Antonia F H ^a   Eijsenga, Simon J ^a   Assendelft, Willem J J ^a   Blom, Jeanet W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acceptance; General practice; Migraine; Preventive treatment; Profylaxis

Indexed keywords

TRIPTAN DERIVATIVE;

ADULT; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG EFFICACY; FEMALE; GENERAL PRACTITIONER; HEADACHE; HEALTH SURVEY; HUMAN; MALE; MIGRAINE; PREVENTIVE MEDICINE; QUESTIONNAIRE; REVIEW;

ADULT; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONERS; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 84866125339     PISSN: 13814788     EISSN: 17511402     Source Type: Journal    
DOI: 10.3109/13814788.2012.708332     Document Type: Review

References (22)

1. Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193- 210. (Pubitemid 46354128)
2. L auner L J, T erwindt G M, F errari M D. T he prevalence and characteristics of migraine in a population-based cohort: The GEM study. Neurology 1999; 53 : 537 - 42. (Pubitemid 29382048)
3. WF, Wood GC, Razzaghi H, Reed ML, Lipton RB. Work impact of migraine headaches. J Occup Environ Med. 2008; 50 : 736 - 45.
4. L ipton R B, B igal M E. T he epidemiology of migraine. A m J Med. 2005; 118 : 3S - 10S.
5. K nuisting Neven A, B artelink M EL, D e Jongh T OH, O ngering J EP, Oosterhuis WW, Van der Weerd PCM, et al. NHG-standaard Hoofdpijn. Huisarts Wet. 2004 ; 46 : 411 - 22. (Pubitemid 39163575)
6. Ramadan N, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines for migraine headache in the primary care setting: Pharmacological management for prevention of migraine; 2000. Available at http://www.neurology.org (accessed 27 January 2012).
7. Couturier EGM, Bomhof MAM, Gooskens RHJM, Keyser A, Mulleners WM. Guidelines diagnosis and treatment of chronic recurrent headache (Dutch); 2007. Available at http://www. neurologie.nl (accessed 27 January 2012).
8. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009; 16 : 968 - 81.
9. British Association for the Study of Headache. Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache; 2007. Available at http://www.bash.org.uk (accessed 27 January 2012).
10. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 30: 343- 9. (Pubitemid 46184209)
11. D iamond S, B igal M E, S ilberstein S, L oder E, R eed M, L ipton R B. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American migraine prevalence and prevention study. Headache 2007; 47: 355- 63. (Pubitemid 46426410)
12. Kol CM, Dekker F, Neven AK, Assendelft WJ, Blom JW. Acceptance or rejection of prophylactic medicine in patients with migraine: A cross-sectional study. Br J Gen Pract. 2008; 58 : 98 - 101. (Pubitemid 351222895)
13. Smelt AF, Blom JW, Dekker F, van den Akker ME, Knuistingh NA, Zitman FG, et al. A proactive approach to migraine in primary care: A pragmatic randomized controlled trial. or Can Med Ass J 2012; 184 : E224 - 31.
14. Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, et al. A six-item short-form survey for measuring headache impact: The HIT-6. Qual Life Res. 2003; 12 : 963 - 74. (Pubitemid 37386625)
15. Donker T, Comijs H, Cuijpers P, Terluin B, Nolen W, Zitman F, et al. The validity of the Dutch K10 and extended K10 screening scales for depressive and anxiety disorders. Psychiatry Res. 2010; 176: 45- 50.
16. D ekker F, K nuistingh N even A, A ndriesse B, K ernick D, R eis R, Ferrari MD, Assendelft WJ. Prophylactic treatment of migraine; the patient's view, a qualitative study. BMC Fam Pract. 2012; 13:13.
17. Rozen TD. Migraine prevention: What patients want from medication and their physicians (a headache specialty clinic perspective). Headache 2006; 46 : 750 - 3.
18. Peres MF, Silberstein S, Moreira F, Corchs F, Vieira DS, Abraham N, et al. Patients' preference for migraine preventive therapy. Headache 2007; 47 : 540 - 5. (Pubitemid 46625262)
19. Linde M, Jonsson P, Hedenrud T. Infl uence of disease features on adherence to prophylactic migraine medication. Acta Neurol Scand. 2008; 118 : 367 - 72.
20. Peters M, Abu-Saad HH, Vydelingum V, Dowson A, Murphy M. Patients ' decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia 2003; 23: 833- 41. (Pubitemid 37255426)
21. Dekker F, Knuistingh Neven A, Andriesse B, Ferrari M D, Assendelft WJJ. Prophylactic treatment of migraine by GPs; a qualitative study. Br J Gen Pract. 2012; 62 : e268 - 74.
22. Goodyear-Smith F, Kenealy T, Wells S, Arroll B, Horsburgh M. Patients ' preferences for ways to communicate benefi ts of cardiovascular medication. Ann Fam Med. 2011; 9: 121- 7